Evidence map›Paper›PMID 30013146›Full record

ArticleNature immunology2018

Epithelial damage and tissue γδ T cells promote a unique tumor-protective IgE response.

Greg Crawford, Mark David Hayes, Rocio Castro Seoane, Sophie Ward, Tim Dalessandri, Chester Lai, Eugene Healy, David Kipling, Charlotte Proby, Colin Moyes and 6 more

Open access · greenAbstract read
In one paragraph

Article in Nature immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 115 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Cutaneous T cell immunity.Nature immunology · 2025
    Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. TSLP: contrasting roles in cancer.Frontiers in immunology · 2025
    Review
  13. Primordial Cells Bridging the Gap Between Innate and Adaptive Immunity.Advances in experimental medicine and biology · 2025
    Review
  14. Anti-Tumor Effects ofToxins · 2024
    Article
  15. Type 2 immunity in the brain and brain borders.Cellular & molecular immunology · 2023
    Review
  16. Review
  17. Review
  18. Article
  19. Prospective assessment of pre-existing andFrontiers in immunology · 2023
    Article
  20. Review

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 8 institutions in 1 country.

Greg CrawfordDepartment of Medicine, Imperial College London, London, UK.
Mark David HayesDepartment of Medicine, Imperial College London, London, UK.
Rocio Castro SeoaneDepartment of Medicine, Imperial College London, London, UK.
Sophie WardDepartment of Medicine, Imperial College London, London, UK.
Tim DalessandriDepartment of Medicine, Imperial College London, London, UK.
Chester LaiDermatopharmacology, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom; Dermatology, University Hospital Southampton NHS Foundation Trust, Southampton, UK.ORCID http://orcid.org/0000-0003-2282-5655
Eugene HealyDermatopharmacology, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom; Dermatology, University Hospital Southampton NHS Foundation Trust, Southampton, UK.ORCID http://orcid.org/0000-0001-5591-6970
David KiplingDivision of Cancer and Genetics, School of Medicine, Cardiff University, Cardiff, UK.ORCID http://orcid.org/0000-0002-0927-5954
Charlotte ProbyDivision of Cancer Research, School of Medicine, University of Dundee, Ninewells Hospital & Medical School, Dundee, UK.
Colin MoyesDepartment of Pathology, Greater Glasgow and Clyde NHS, Queen Elizabeth University Hospital, Glasgow, UK.
Kile GreenInstitute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.
Katie BestInstitute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.
Muzlifah HaniffaInstitute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.ORCID http://orcid.org/0000-0002-3927-2084
Marina BottoDepartment of Medicine, Imperial College London, London, UK.
Deborah Dunn-WaltersFaculty of Health and Medical Sciences, School of Biosciences and Medicine, University of Surrey, Guildford, Surrey, UK.
Jessica StridDepartment of Medicine, Imperial College London, London, UK. j.strid@imperial.ac.uk.ORCID http://orcid.org/0000-0003-3690-2201
Imperial College London · GBNewcastle upon Tyne Hospitals NHS Foundation Trust · GBUniversity Hospital Southampton NHS Foundation Trust · GBCardiff University · GBNewcastle University · GBQueen Elizabeth University Hospital · GBUniversity of Dundee · GBUniversity of Surrey · GB

Funding

Cancer Research UK 13044Cancer Research UK 19788Cancer Research UK A19788Medical Research Council MR/L01257X/1Medical Research Council MR/L01257X/2Wellcome Trust 100999
6 · The paper itself

Abstract

IgE is an ancient and conserved immunoglobulin isotype with potent immunological function. Nevertheless, the regulation of IgE responses remains an enigma, and evidence of a role for IgE in host defense is limited. Here we report that topical exposure to a common environmental DNA-damaging xenobiotic initiated stress surveillance by γδTCR

Indexed as

AnimalsAnthracenesB-LymphocytesCarcinoma, Squamous CellCell DeathCells, CulturedComplementarity Determining RegionsDNA DamageEpithelial CellsFemaleHigh-Throughput Nucleotide SequencingImmunoglobulin Class SwitchingImmunoglobulin EImmunologic SurveillanceIntraepithelial LymphocytesMice3-(2,6-bis(4-fluorophenyl)-3-methylpiperidin-4-ylideneamino)-2-thioxoimidazolidin-4-one on 7,12-dimethylbenz(a)anthraceneAnthracenesComplementarity Determining RegionsFcepsilonRIalpha protein, mouseImmunoglobulin EPiperidinesReceptors, Antigen, T-Cell, gamma-deltaReceptors, IgE

Identifiers

PMID30013146
PMCPMC6071860
OpenAlexW2884289363

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.